Scientific Advisory Board
Our Scientific Advisory Board provides strategic guidance and direction that benefits the quality of the scientific research carried out at the Princess Máxima Center. Integrating care and research means that the scientific discoveries can be directly applied to the treatment of childhood cancer patients.
The Scientific Advisory Board advises the Board of Directors of the Princess Máxima Center on setting up the research program, the infrastructure, and strategic partnerships for research. The Board consists (inter)national members who have been asked to join on the basis of their exceptional knowledge and expertise in (pediatric) oncology research.
The Scientific Advisory Board of the Princess Máxima Center consists of the following distinguished members:
Prof. Dr. Martin Eilers (Chair) - Tumorigenesis, University of Würzburg, Biocenter, Würzburg, Germany
Prof. Dr. Ton Schumacher (Co-chair) - Cancer Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands
Prof. Dr. Richard Gilbertson - Cellular and molecular origins of cancer, University of Cambridge, Cambridge, UK
Prof. Dr. Anton Henssen - Center for Experimental and Clinical Research, Max Delbrück Center (MDC) and Charité University Hospital Berlin, Berlin, Germany
Prof. Dr. Anne May - Clinical cancer epidemiology, UMC Utrecht, Utrecht, the Netherlands
Dr. Julie Park - Developmental and translational childhood cancer research, St. Jude Children’s Research Hospital, Memphis, TN, USA
Prof. Dr. Kimberley Stegmaier - Cancer genomics, Dana-Farber Cancer Institute, Boston, MA, USA